Cardiac MRI shown to improve diagnosis in patients with life-threatening arrhythmias

New research from Western University, Canada, has demonstrated the benefits of performing Cardiovascular Magnetic Resonance (CMR) in cases where patients have been resuscitated after Sudden Cardiac Death or enter hospital suffering from ventricular arrhythmias (abnormal heartbeat rhythm). Cardiologist Dr. James White and his colleagues at Western's Schulich School of Medicine & Dentistry, found CMR is a highly effective diagnostic imaging tool, identifying a cardiac diagnosis in 75 per cent of cases compared with only 50 per cent in all other testing. Overall, CMR identified a new or alternate explanation for the arrhythmia in 50 per cent of patients. The findings are published in Circulation: Cardiovascular Imaging, a Journal of the American Heart Association.

The study tested the impact of performing CMR in 82 consecutive that presented to hospital with either resuscitated or Ventricular Tachycardia. "In these cases, there is a fear of recurrence, so we want to identify what might be at the root of the rhythm," explains Dr. White, the Director of the Cardiovascular MRI Clinical Research Program at Schulich's Robarts Research Institute.

This video is not supported by your browser at this time.
Cardiologist Dr. James White of Western University has demonstrated the benefits of performing cardiovascular magnetic resonance (CMR) in cases where patients have been resuscitated after sudden cardiac death or enter hospital suffering from ventricular arrhythmias (abnormal heartbeat rhythm). The research shows CMR is a highly effective diagnostic imaging tool, identifying a cardiac diagnosis in 75 percent of cases compared with only 50 per cent in all other testing. Overall, CMR identified a new or alternate explanation for the arrhythmia in 50 percent of patients. Credit: Schulich School of Medicine & Dentistry, Western University

Standard cardiac imaging tests were conducted in all patients. But the researchers also used a 3-Tesla MRI at the Robarts Research Institute to evaluate whether they could find an answer with one test. "What we found was interesting. In three-quarters of the patients who had an MRI performed, we were able to identify a plausible reason why that heart occurred. When we looked at the conventional testing and in only half the patients found a cause. So this made a very big and incremental difference to our diagnosis of these patients. We also found that about 50 per cent of the time, we provided either a new or alternate diagnosis for this patient population." Often the patients were found to have inflammation of the heart muscle or small heart attacks that had gone undetected.

The research was conducted in conjunction with the arrhythmia department at London Health Sciences Centre (LHSC). Dr. White is a Cardiologist and a scientist with Robarts and the Biomedical Imaging Research Centre (BIRC) at Western and Lawson Health Research Institute. He is an assistant professor in the Department of Medicine at Schulich Medicine & Dentistry and practices within the Division of Cardiology at the LHSC.

Provided by University of Western Ontario

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Study shows fainting factor in cardiac arrests

Feb 09, 2012

A new study by Dr. Andrew Krahn shows that over a quarter of unexplained cardiac arrests occurred after the patient had an event of fainting, known as syncope. According to Dr. Krahn, a Cardiologist at London Health Sciences ...

Heart scan could replace angiogram for some patients

Sep 08, 2011

A study published today in the journal Circulation showed that a cardiac magnetic resonance (CMR) scan is as accurate as an angiogram in diagnosing the causes of heart failure in patients with dilated cardiomyopathy. The ...

New guidelines for cardiovascular genetic testing

May 06, 2011

An international panel of experts from The Heart Rhythm Society and the European Heart Rhythm Association issued new guideline recommendations for all health care professionals about cardiovascular genetic testing at the ...

Recommended for you

NT-proBNP modestly improves CVD risk prediction in women

20 hours ago

(HealthDay)—N-terminal pro-B-type natriuretic peptide (NT-proBNP) modestly improves cardiovascular disease (CVD) risk prediction for women, according to a study published in the Oct. 28 issue of the Journal of ...

User comments